| Filed On | Filing |
|---|---|
| 07 Oct 2026 |
Form 4: Gyftakis Stavros, See Remarks
Sold 2,835 shares ($49.7K) |
| 02 Oct 2026 | 6-K |
| 21 Sep 2026 | SCHEDULE 13G/A |
| 07 Aug 2026 |
Form 4: Anagnostara Christina, Director
Sold 15,000 shares ($258K) |
| 06 Aug 2026 | 144 |
| 06 Aug 2026 | 6-K |
| 15 Jul 2026 |
Form 4: Gyftakis Stavros, See Remarks
Sold 3,300 shares ($48.9K) |
| 08 Jul 2026 | 6-K |
| 01 Jul 2026 | 6-K |
| 29 May 2026 | 6-K |
| 08 Apr 2026 |
Form 4: Gyftakis Stavros, See Remarks
Sold 3,570 shares ($49.8K) |
| 08 Apr 2026 | SCHEDULE 13G/A |
| 01 Apr 2026 | 6K |
| 31 Mar 2026 | 8-A12B/A |
| 31 Mar 2026 | SCHEDULE 13D/A |
| 31 Mar 2026 | 20-F |
| 18 Mar 2026 |
Form 3: Gyftakis Stavros, See Remarks
Holds 240,045 shares of Shares of Common Stock, par value $0.0001 per share |
| 18 Mar 2026 | 6-K |
| 18 Mar 2026 |
Form 3: Culucundis Elias, Director
Holds 72,800 shares of Shares of Common Stock, par value $0.0001 per share |
| 18 Mar 2026 |
Form 3: Anagnostara Christina, Director
Holds 193,239 shares of Shares of Common Stock, par value $0.0001 per share |
Loading...
